Ensysce Biosciences, Inc. (ENSC)
0.5312
+0.02
(+3.35%)
USD |
NASDAQ |
Mar 31, 12:36
Ensysce Biosciences EPS Diluted (Quarterly) : -1.292 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.729M |
| Revenue (Quarterly) | 0.4931M |
| Total Expenses (Quarterly) | 4.222M |
| Enterprise Value | 0.2293M |
| Profit Margin (Quarterly) | -756.3% |
| Earnings Yield | -1.15K% |
| Normalized Earnings Yield | -1148.00 |